LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) Director Ra Capital Management, L.P. purchased 998,009 shares of the company’s stock in a transaction that occurred on Thursday, March 21st. The shares were purchased at an average price of $15.03 per share, for a total transaction of $15,000,075.27. Following the completion of the transaction, the director […]